What are the differences between peritoneal (peritoneal dialysis) and hemodialysis (hemodialysis), including pros and cons for each?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Peritoneal Dialysis vs Hemodialysis: Key Differences and Clinical Selection

Both peritoneal dialysis (PD) and hemodialysis (HD) provide similar long-term survival outcomes in patients eligible for both modalities, but PD offers greater patient autonomy, lower costs, and may provide a survival advantage in the first 1.5-2 years of dialysis, particularly in younger patients and those with residual kidney function. 1, 2, 3

Fundamental Mechanistic Differences

Peritoneal Dialysis

  • Uses the peritoneum as a natural semipermeable membrane with blood flow from peritoneal microcirculation, eliminating the need for an extracorporeal circuit 4
  • Removes solutes through diffusion (primary mechanism for small molecules) and convection (solvent drag during ultrafiltration) 4
  • Achieves only 10-20% of normal kidney clearance for urea and creatinine, with even lower clearance for higher molecular weight solutes 4
  • Continuous 24-hour treatment maximizes middle molecule clearance 4

Hemodialysis

  • Requires vascular access and extracorporeal blood circuit with artificial membrane 1
  • Typically performed 3 times weekly in-center, though home HD options exist 1
  • Provides intermittent but more intensive solute clearance per session 1

Survival Outcomes: The Critical Timeline

The survival advantage of PD is time-dependent and changes predictably over the dialysis course. 2, 5

  • First 3 months: PD shows lower mortality risk compared to in-center HD 2
  • First 1.5-2 years: PD survival advantage continues, especially in non-diabetic and younger diabetic patients 2, 5
  • Beyond 2 years: Mortality risk with PD equals or exceeds HD, depending on patient factors 2
  • Among patients eligible for both modalities: No significant survival difference at any time point 3

Critical caveat: The apparent early PD survival advantage in population studies may reflect selection bias rather than true modality effect, as healthier patients often choose PD 6, 3

Advantages of Peritoneal Dialysis

Patient-Centered Benefits

  • Greater autonomy and treatment satisfaction compared to in-center HD 1
  • Home-based therapy allows flexibility in scheduling and lifestyle 1, 7
  • Preservation of residual kidney function longer than HD 7
  • Lower treatment costs to healthcare system 1, 2, 7

Clinical Benefits

  • Better preservation of residual renal function, particularly important early in dialysis 7
  • Continuous solute and fluid removal provides more stable hemodynamics 4
  • No need for vascular access, avoiding catheter-related bloodstream infections 2

Disadvantages of Peritoneal Dialysis

Infection Risks

  • Peritonitis remains the primary complication, with unacceptably frequent episodes requiring modality switch 1
  • Diverticulitis during PD often results in peritonitis 1
  • Abdominal or chest wall infections can contaminate catheter exit site and peritoneal cavity 8

Nutritional Concerns

  • Continuous protein loss through peritoneum can contribute to malnutrition 1, 4
  • Excessive protein losses occur in high transporters, active nephrosis, or frequent peritonitis 1
  • Increased caloric absorption from glucose-based dialysate may worsen obesity 1

Technical Limitations

  • High technique failure rate persists despite reduced peritonitis rates 2
  • Inadequate ultrafiltration in high transporters may require burdensome short-dwell regimens 1
  • Low transporters in large patients may have inadequate peritoneal clearance 1
  • Mechanical problems (catheter malposition, hernias, leaks) can necessitate modality switch 1

Metabolic Issues

  • Unmanageably severe hypertriglyceridemia from dextrose load may increase cardiovascular risk 1

Advantages of Hemodialysis

  • More efficient solute clearance per treatment session 1
  • No continuous protein losses 4
  • Suitable for patients with peritoneal membrane failure or extensive abdominal adhesions 8
  • Direct supervision by healthcare professionals during treatment 1
  • Better option for patients unable to perform self-care or lacking suitable care-partner 8

Disadvantages of Hemodialysis

  • Vascular access complications, particularly catheter-related bloodstream infections 2
  • Requires travel to dialysis center 3 times weekly (for in-center HD) 1
  • Less patient autonomy and lifestyle flexibility 1
  • Intermittent treatment causes hemodynamic instability in some patients 4
  • Higher costs to healthcare system 1, 2, 7
  • Faster loss of residual kidney function 7

Absolute Contraindications to Peritoneal Dialysis

PD should not be offered when: 8

  • Documented loss of peritoneal function or extensive abdominal adhesions limiting dialysate flow 8
  • Patient physically or mentally unable to perform PD without suitable assistant 8
  • Uncorrectable mechanical defects (irreparable hernias, omphalocele, gastroschisis, diaphragmatic hernia, bladder exstrophy) 8

Relative Contraindications to Peritoneal Dialysis

Consider HD instead when: 1, 8

  • Recent intra-abdominal foreign bodies (require 4-month waiting period after vascular prostheses or ventriculoperitoneal shunt) 8
  • Morbid obesity creating catheter placement problems or risk of further weight gain 1, 8
  • Severe malnutrition with compromised wound healing 1, 8
  • Frequent diverticulitis episodes 1, 8
  • Inflammatory or ischemic bowel disease 8
  • Body size extremes (too small for prescribed volumes or too large for adequate dialysis) 8

Mandatory Indications for Switching from PD to HD

Transfer from PD to HD is required when: 1

  • Consistent failure to achieve target Kt/Vurea and creatinine clearance despite optimal prescription 1
  • Inadequate ultrafiltration or solute transport unresponsive to prescription adjustments 1
  • Unacceptably frequent peritonitis or PD-related complications 1
  • Irreparable technical/mechanical catheter problems 1
  • Severe malnutrition resistant to aggressive management 1
  • Unmanageably severe hypertriglyceridemia 1

Clinical Decision Algorithm

For incident dialysis patients with residual kidney function and no contraindications:

  • Start with PD to maximize early survival advantage, preserve residual function, and provide lifestyle flexibility 2, 5, 7
  • Plan for "healthy start" integrated care approach with timely transfer to HD when complications arise 5

For elderly or frail patients:

  • Consider PD with home nursing support to enable home-based therapy 7
  • Evaluate care-partner availability and patient's physical/cognitive ability 8

For patients with severe comorbidities or limited life expectancy:

  • Either modality appropriate based on patient preference, as survival outcomes are similar 3
  • Prioritize quality of life and treatment satisfaction in decision-making 1

For patients with contraindications to PD:

  • HD is the appropriate choice when absolute contraindications exist 8
  • Relative contraindications require individualized risk-benefit assessment 8

Common Pitfalls to Avoid

  • Failing to provide high-quality pre-dialysis education about both modalities leads to physician bias determining modality rather than informed patient choice 1, 2
  • Keeping patients on failing PD too long when clear indications for HD transfer exist increases morbidity and mortality 1
  • Assuming PD survival advantage persists indefinitely when evidence shows it diminishes after 1.5-2 years 2
  • Not planning vascular access early in PD patients who will eventually need HD 1
  • Ignoring protein losses and malnutrition in PD patients, which increases mortality risk 1, 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Comparison of Patient Survival Between Hemodialysis and Peritoneal Dialysis Among Patients Eligible for Both Modalities.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2018

Guideline

Peritoneal Dialysis Mechanism and Physiology

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Peritoneal dialysis or hemodialysis? A dilemma for the nephrologist.

Advances in peritoneal dialysis. Conference on Peritoneal Dialysis, 2006

Guideline

Peritoneal Dialysis Contraindications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.